NAYA Biosciences (NASDAQ:NAYA) Upgraded at Maxim Group

NAYA Biosciences (NASDAQ:NAYA) was upgraded by equities researchers at Maxim Group from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a $2.00 target price on the stock. Maxim Group’s price target suggests a potential upside of 342.48% from the stock’s current price.

NAYA Biosciences Price Performance

NASDAQ:NAYA traded down $0.00 during trading hours on Thursday, reaching $0.45. The company had a trading volume of 56,665 shares, compared to its average volume of 450,476. NAYA Biosciences has a one year low of $0.41 and a one year high of $3.50. The business has a 50-day simple moving average of $0.77.

About NAYA Biosciences

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.